nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—retina—malignant glioma	0.0378	0.0933	CbGeAlD
Miglustat—UGCG—retina—malignant glioma	0.0373	0.092	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYB—malignant glioma	0.0372	0.121	CbGpPWpGaD
Miglustat—GBA2—telencephalon—malignant glioma	0.0348	0.0858	CbGeAlD
Miglustat—UGCG—telencephalon—malignant glioma	0.0343	0.0846	CbGeAlD
Miglustat—GBA2—medulla oblongata—malignant glioma	0.0273	0.0674	CbGeAlD
Miglustat—UGCG—medulla oblongata—malignant glioma	0.0269	0.0665	CbGeAlD
Miglustat—GBA2—Sphingolipid metabolism—SPHK1—malignant glioma	0.0256	0.0836	CbGpPWpGaD
Miglustat—GBA2—midbrain—malignant glioma	0.025	0.0616	CbGeAlD
Miglustat—UGCG—midbrain—malignant glioma	0.0246	0.0608	CbGeAlD
Miglustat—GBA2—spinal cord—malignant glioma	0.0244	0.0601	CbGeAlD
Miglustat—UGCG—spinal cord—malignant glioma	0.024	0.0593	CbGeAlD
Miglustat—UGCG—Sphingolipid metabolism—SPHK1—malignant glioma	0.0234	0.0765	CbGpPWpGaD
Miglustat—GBA2—central nervous system—malignant glioma	0.0198	0.0488	CbGeAlD
Miglustat—UGCG—central nervous system—malignant glioma	0.0195	0.0481	CbGeAlD
Miglustat—GBA2—cerebellum—malignant glioma	0.0193	0.0477	CbGeAlD
Miglustat—UGCG—cerebellum—malignant glioma	0.019	0.047	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—TERT—malignant glioma	0.0175	0.0573	CbGpPWpGaD
Miglustat—GBA2—brain—malignant glioma	0.0157	0.0387	CbGeAlD
Miglustat—UGCG—brain—malignant glioma	0.0155	0.0382	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PTPN11—malignant glioma	0.0145	0.0474	CbGpPWpGaD
Miglustat—Disorder sight—Temozolomide—malignant glioma	0.0144	0.0498	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—BCL2—malignant glioma	0.0118	0.0386	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—IL2—malignant glioma	0.0104	0.034	CbGpPWpGaD
Miglustat—Influenza-like symptoms—Temozolomide—malignant glioma	0.0096	0.0332	CcSEcCtD
Miglustat—Coagulopathy—Temozolomide—malignant glioma	0.00881	0.0305	CcSEcCtD
Miglustat—Memory impairment—Temozolomide—malignant glioma	0.00874	0.0302	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYC—malignant glioma	0.00812	0.0266	CbGpPWpGaD
Miglustat—Gait disturbance—Carmustine—malignant glioma	0.00727	0.0251	CcSEcCtD
Miglustat—Gait disturbance—Temozolomide—malignant glioma	0.00703	0.0243	CcSEcCtD
Miglustat—GBA2—Metabolism—RTEL1—malignant glioma	0.007	0.0229	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PIK3CA—malignant glioma	0.0069	0.0226	CbGpPWpGaD
Miglustat—Neuropathy—Carmustine—malignant glioma	0.00666	0.023	CcSEcCtD
Miglustat—Influenza like illness—Temozolomide—malignant glioma	0.00666	0.023	CcSEcCtD
Miglustat—Neuropathy—Temozolomide—malignant glioma	0.00644	0.0223	CcSEcCtD
Miglustat—UGCG—Metabolism—RTEL1—malignant glioma	0.0064	0.0209	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—AKT1—malignant glioma	0.00563	0.0184	CbGpPWpGaD
Miglustat—Amnesia—Carmustine—malignant glioma	0.00548	0.019	CcSEcCtD
Miglustat—Amnesia—Temozolomide—malignant glioma	0.0053	0.0183	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.005	0.0164	CbGpPWpGaD
Miglustat—Ataxia—Carmustine—malignant glioma	0.00484	0.0167	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00484	0.0158	CbGpPWpGaD
Miglustat—Ataxia—Temozolomide—malignant glioma	0.00468	0.0162	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.00457	0.015	CbGpPWpGaD
Miglustat—Muscular weakness—Carmustine—malignant glioma	0.00454	0.0157	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00443	0.0145	CbGpPWpGaD
Miglustat—Muscular weakness—Temozolomide—malignant glioma	0.00439	0.0152	CcSEcCtD
Miglustat—Abdominal distension—Temozolomide—malignant glioma	0.00433	0.015	CcSEcCtD
Miglustat—GBA2—Metabolism—COX8A—malignant glioma	0.00402	0.0131	CbGpPWpGaD
Miglustat—Depression—Carmustine—malignant glioma	0.00396	0.0137	CcSEcCtD
Miglustat—Weight decreased—Temozolomide—malignant glioma	0.00389	0.0135	CcSEcCtD
Miglustat—Neuropathy peripheral—Carmustine—malignant glioma	0.00389	0.0135	CcSEcCtD
Miglustat—Depression—Temozolomide—malignant glioma	0.00383	0.0132	CcSEcCtD
Miglustat—Neuropathy peripheral—Temozolomide—malignant glioma	0.00376	0.013	CcSEcCtD
Miglustat—UGCG—Metabolism—COX8A—malignant glioma	0.00368	0.012	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00359	0.0117	CbGpPWpGaD
Miglustat—Haemoglobin—Carmustine—malignant glioma	0.00358	0.0124	CcSEcCtD
Miglustat—Haemorrhage—Carmustine—malignant glioma	0.00356	0.0123	CcSEcCtD
Miglustat—Hypoaesthesia—Carmustine—malignant glioma	0.00355	0.0123	CcSEcCtD
Miglustat—Connective tissue disorder—Carmustine—malignant glioma	0.0035	0.0121	CcSEcCtD
Miglustat—Haemoglobin—Temozolomide—malignant glioma	0.00346	0.012	CcSEcCtD
Miglustat—Haemorrhage—Temozolomide—malignant glioma	0.00344	0.0119	CcSEcCtD
Miglustat—Visual impairment—Carmustine—malignant glioma	0.00343	0.0119	CcSEcCtD
Miglustat—Hypoaesthesia—Temozolomide—malignant glioma	0.00343	0.0118	CcSEcCtD
Miglustat—GBA2—Metabolism—ASMT—malignant glioma	0.00342	0.0112	CbGpPWpGaD
Miglustat—Connective tissue disorder—Temozolomide—malignant glioma	0.00338	0.0117	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00334	0.0109	CbGpPWpGaD
Miglustat—Eye disorder—Carmustine—malignant glioma	0.00333	0.0115	CcSEcCtD
Miglustat—Visual impairment—Temozolomide—malignant glioma	0.00332	0.0115	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.00329	0.0107	CbGpPWpGaD
Miglustat—Eye disorder—Temozolomide—malignant glioma	0.00322	0.0111	CcSEcCtD
Miglustat—GBA2—Metabolism—BCAN—malignant glioma	0.00321	0.0105	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ASMT—malignant glioma	0.00313	0.0102	CbGpPWpGaD
Miglustat—Mental disorder—Carmustine—malignant glioma	0.00312	0.0108	CcSEcCtD
Miglustat—Malnutrition—Carmustine—malignant glioma	0.0031	0.0107	CcSEcCtD
Miglustat—Chills—Temozolomide—malignant glioma	0.00309	0.0107	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.00305	0.00999	CbGpPWpGaD
Miglustat—Mental disorder—Temozolomide—malignant glioma	0.00302	0.0104	CcSEcCtD
Miglustat—Back pain—Carmustine—malignant glioma	0.003	0.0104	CcSEcCtD
Miglustat—Malnutrition—Temozolomide—malignant glioma	0.003	0.0104	CcSEcCtD
Miglustat—UGCG—Metabolism—BCAN—malignant glioma	0.00294	0.00961	CbGpPWpGaD
Miglustat—Tremor—Carmustine—malignant glioma	0.00291	0.0101	CcSEcCtD
Miglustat—Back pain—Temozolomide—malignant glioma	0.0029	0.01	CcSEcCtD
Miglustat—Tremor—Temozolomide—malignant glioma	0.00281	0.00971	CcSEcCtD
Miglustat—Ill-defined disorder—Temozolomide—malignant glioma	0.00278	0.00962	CcSEcCtD
Miglustat—Malaise—Temozolomide—malignant glioma	0.0027	0.00935	CcSEcCtD
Miglustat—Vertigo—Temozolomide—malignant glioma	0.00269	0.00931	CcSEcCtD
Miglustat—Convulsion—Carmustine—malignant glioma	0.00269	0.00929	CcSEcCtD
Miglustat—Convulsion—Temozolomide—malignant glioma	0.0026	0.00898	CcSEcCtD
Miglustat—GBA2—Metabolism—IDH2—malignant glioma	0.00259	0.00847	CbGpPWpGaD
Miglustat—Discomfort—Temozolomide—malignant glioma	0.00252	0.00872	CcSEcCtD
Miglustat—Dry mouth—Temozolomide—malignant glioma	0.0025	0.00863	CcSEcCtD
Miglustat—Thrombocytopenia—Carmustine—malignant glioma	0.00248	0.00857	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00244	0.00798	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CYP2B6—malignant glioma	0.00243	0.00796	CbGpPWpGaD
Miglustat—Anorexia—Carmustine—malignant glioma	0.00241	0.00835	CcSEcCtD
Miglustat—Nervous system disorder—Temozolomide—malignant glioma	0.0024	0.0083	CcSEcCtD
Miglustat—Thrombocytopenia—Temozolomide—malignant glioma	0.0024	0.00828	CcSEcCtD
Miglustat—UGCG—Metabolism—IDH2—malignant glioma	0.00237	0.00774	CbGpPWpGaD
Miglustat—Anorexia—Temozolomide—malignant glioma	0.00233	0.00806	CcSEcCtD
Miglustat—Insomnia—Carmustine—malignant glioma	0.00229	0.00792	CcSEcCtD
Miglustat—Paraesthesia—Carmustine—malignant glioma	0.00227	0.00786	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.00223	0.0073	CbGpPWpGaD
Miglustat—GBA2—Metabolism—IDH1—malignant glioma	0.00223	0.00728	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CYP2B6—malignant glioma	0.00223	0.00728	CbGpPWpGaD
Miglustat—Insomnia—Temozolomide—malignant glioma	0.00221	0.00765	CcSEcCtD
Miglustat—Decreased appetite—Carmustine—malignant glioma	0.0022	0.00761	CcSEcCtD
Miglustat—Paraesthesia—Temozolomide—malignant glioma	0.0022	0.0076	CcSEcCtD
Miglustat—Gastrointestinal disorder—Carmustine—malignant glioma	0.00219	0.00756	CcSEcCtD
Miglustat—Constipation—Carmustine—malignant glioma	0.00217	0.00749	CcSEcCtD
Miglustat—Pain—Carmustine—malignant glioma	0.00217	0.00749	CcSEcCtD
Miglustat—GBA2—Metabolism—SPHK1—malignant glioma	0.00215	0.00705	CbGpPWpGaD
Miglustat—Dyspepsia—Temozolomide—malignant glioma	0.00215	0.00745	CcSEcCtD
Miglustat—Decreased appetite—Temozolomide—malignant glioma	0.00213	0.00735	CcSEcCtD
Miglustat—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00211	0.0073	CcSEcCtD
Miglustat—GBA2—Metabolism—CYP2C18—malignant glioma	0.00211	0.0069	CbGpPWpGaD
Miglustat—Fatigue—Temozolomide—malignant glioma	0.00211	0.00729	CcSEcCtD
Miglustat—Constipation—Temozolomide—malignant glioma	0.00209	0.00724	CcSEcCtD
Miglustat—Pain—Temozolomide—malignant glioma	0.00209	0.00724	CcSEcCtD
Miglustat—Feeling abnormal—Carmustine—malignant glioma	0.00209	0.00721	CcSEcCtD
Miglustat—Gastrointestinal pain—Carmustine—malignant glioma	0.00207	0.00716	CcSEcCtD
Miglustat—UGCG—Metabolism—IDH1—malignant glioma	0.00204	0.00666	CbGpPWpGaD
Miglustat—Feeling abnormal—Temozolomide—malignant glioma	0.00202	0.00697	CcSEcCtD
Miglustat—Abdominal pain—Carmustine—malignant glioma	0.002	0.00692	CcSEcCtD
Miglustat—Gastrointestinal pain—Temozolomide—malignant glioma	0.002	0.00692	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00199	0.00651	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SPHK1—malignant glioma	0.00197	0.00644	CbGpPWpGaD
Miglustat—Abdominal pain—Temozolomide—malignant glioma	0.00193	0.00669	CcSEcCtD
Miglustat—UGCG—Metabolism—CYP2C18—malignant glioma	0.00193	0.00631	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00182	0.00595	CbGpPWpGaD
Miglustat—Asthenia—Carmustine—malignant glioma	0.00182	0.00628	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00181	0.00593	CbGpPWpGaD
Miglustat—Asthenia—Temozolomide—malignant glioma	0.00176	0.00607	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00175	0.00572	CbGpPWpGaD
Miglustat—Diarrhoea—Carmustine—malignant glioma	0.00173	0.00599	CcSEcCtD
Miglustat—GBA2—Metabolism—GSTT1—malignant glioma	0.00171	0.00558	CbGpPWpGaD
Miglustat—Dizziness—Carmustine—malignant glioma	0.00167	0.00579	CcSEcCtD
Miglustat—Diarrhoea—Temozolomide—malignant glioma	0.00167	0.00579	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.00166	0.00542	CbGpPWpGaD
Miglustat—Dizziness—Temozolomide—malignant glioma	0.00162	0.00559	CcSEcCtD
Miglustat—Vomiting—Carmustine—malignant glioma	0.00161	0.00557	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.0016	0.00523	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTGS1—malignant glioma	0.0016	0.00523	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00159	0.00521	CbGpPWpGaD
Miglustat—Headache—Carmustine—malignant glioma	0.00159	0.00548	CcSEcCtD
Miglustat—UGCG—Metabolism—GSTT1—malignant glioma	0.00156	0.00511	CbGpPWpGaD
Miglustat—Vomiting—Temozolomide—malignant glioma	0.00156	0.00538	CcSEcCtD
Miglustat—Headache—Temozolomide—malignant glioma	0.00153	0.0053	CcSEcCtD
Miglustat—Nausea—Carmustine—malignant glioma	0.0015	0.0052	CcSEcCtD
Miglustat—GBA2—Metabolism—BCHE—malignant glioma	0.00149	0.00486	CbGpPWpGaD
Miglustat—GBA2—Metabolism—SLC5A5—malignant glioma	0.00147	0.0048	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTGS1—malignant glioma	0.00146	0.00478	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.00146	0.00477	CbGpPWpGaD
Miglustat—Nausea—Temozolomide—malignant glioma	0.00145	0.00503	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00139	0.00454	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00138	0.0045	CbGpPWpGaD
Miglustat—UGCG—Metabolism—BCHE—malignant glioma	0.00136	0.00445	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC5A5—malignant glioma	0.00134	0.00439	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.00127	0.00416	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.00126	0.00412	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.0012	0.00393	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GSTP1—malignant glioma	0.00118	0.00387	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CAT—malignant glioma	0.00115	0.00377	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.0011	0.00359	CbGpPWpGaD
Miglustat—GBA2—Metabolism—NCOR1—malignant glioma	0.00109	0.00356	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GSTP1—malignant glioma	0.00108	0.00354	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CAT—malignant glioma	0.00105	0.00344	CbGpPWpGaD
Miglustat—UGCG—Metabolism—NCOR1—malignant glioma	0.000995	0.00325	CbGpPWpGaD
Miglustat—GBA2—Metabolism—CAV1—malignant glioma	0.000887	0.0029	CbGpPWpGaD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000847	0.00277	CbGpPWpGaD
Miglustat—UGCG—Metabolism—CAV1—malignant glioma	0.000811	0.00265	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CG—malignant glioma	0.000808	0.00264	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PPARG—malignant glioma	0.000779	0.00255	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000775	0.00253	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CG—malignant glioma	0.000739	0.00242	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PPARG—malignant glioma	0.000713	0.00233	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CD—malignant glioma	0.00071	0.00232	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CD—malignant glioma	0.000649	0.00212	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CB—malignant glioma	0.000619	0.00202	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTGS2—malignant glioma	0.000613	0.002	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CB—malignant glioma	0.000566	0.00185	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTGS2—malignant glioma	0.000561	0.00183	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PTEN—malignant glioma	0.000535	0.00175	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PTEN—malignant glioma	0.000489	0.0016	CbGpPWpGaD
Miglustat—GBA2—Metabolism—PIK3CA—malignant glioma	0.000377	0.00123	CbGpPWpGaD
Miglustat—UGCG—Metabolism—PIK3CA—malignant glioma	0.000345	0.00113	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—malignant glioma	0.000308	0.00101	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—malignant glioma	0.000282	0.000922	CbGpPWpGaD
